Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Genetic Technologies Ltd (GENE)

NASDAQ
Currency in USD
Disclaimer
2.180
-0.070(-3.11%)
Closed
After Hours
2.200+0.020(+0.917%)

GENE Comments

https://www.asx.com.au/asxpdf/20200911/pdf/44mjz484yj5dxf.pdf
Preliminary financial report for the year ending 30 June 2020: https://www.asx.com.au/asxpdf/20200831/pdf/44m406nxrvd04t.pdf
Up we go again. But why?
Seems we are in wait and see waters again. No news last 2 weeks. Suddenly something happens again and we will get another spike. Until then, wait and hold on to your shares. They will slowly dwindle down. When it kicks upwards you will not be quick enough to jump back in.
No real news lately. You can check announcements yourself on www.asx.com. Look for announcements and filter for GTG. GTG is the same companys ticker on the Australian Stock Exchange.  1 GENE = 600 GTG, The volumes are much bigger on Nasdaq (GENE) than on ASX (GTG) - hence a less jerky movement in stock prices. According to the last announcement 71,5% of the shares in Genetic Technologies Ltd are now held via GENE (American Depository shares).
Hey Mr risk, have any updates?
https://www.asx.com.au/asxpdf/20200729/pdf/44kyn1b51mw19k.pdf
Any news?
sell?
Flies today!
this is depressing, whats your thoughts?
What is it that the market does not understand from this? https://www.asx.com.au/asxpdf/20200720/pdf/44knws7hqxykd6.pdf
 Positive stuff: They confirm that they are developing a Covid-19 severity test. It is based on genetic data from Covid patients that they are getting access to. They confirm that this test only costs 1-1.5 MUSD to develop, can be ready in 45 days and will not require FDA approval as it is not a treatment, just a laboratory test. I guess the test is based on DNA sequencing and statistics based on the patient data they have access to. They need sample data from various bio-banks and hospitals for cross-reference and verification purposes - they expect to get this within 30 days. They confirm dialogue with Thermo Fischer Scientific around scaling up Covid-19 severity risk testing to 250K-360K annually. On the negative side: They have almost no business these days from their breast and colon cancer testing as patients are not seeing their doctors as much these days.
Neutral: Their testing and analysis capacity has so far not been requested by Australian government as there has been sufficient testing capacity elsewhere. My guess on what a Covid-19 severity test is: - Some get fatally sick from Covid-19 - others have just a mild reaction. To be able to predict who needs to be super careful can be important. Probably these people should be vaccinated first when a safe vaccine is ready.
Tnx mate for informing us
scheesh... this one *******
What happens with this stock
https://ausstocks.com.au/wp-content/uploads/austocks/gtg/2020_07_17_GTG_f5645a8cb611ea9a65df1b49032c502c.pdf
Sooo? We getting $5 a share ir what? Should hsve sold at $9 smh
https://www.nasdaq.com/press-release/genetic-technologies-announces-$5.1-million-registered-direct-offering-2020-07-16
trading is halted for this share http://www.publicnow.com/view/04190F5F594E1CBFF8D803CA6995B9C33AD11980?1594867594
why??
 news will come out before 20th and dont know exactly
20th? Wth?
Buy htbx......
Dip
no no no....sell sell sell
Will hit 12
The GREED is strong with this one :)
Will hit 10 or down
Buy or not ?
where can we buy it? which app?
looks like a 100bn cap. $4.33 see u at $14 . Jan 26, 2020 sun
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.